TRCT
TRIB

Tower Research Capital (TRC)’s Trinity Biotech TRIB Stock Holding History

Tower Research Capital (TRC)’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1
Closed – – 4362
2019
Q3 		$0 Sell
1
-9
-90% -$2.35K ﹤0.01% 4514
2019
Q2 		$2K Sell
10
-82
-89% -$29.3K ﹤0.01% 3318
2019
Q1 		$39K Buy
92
+14
+18% +$5.77K ﹤0.01% 1895
2018
Q4 		$27K Sell
78
-20
-20% -$9.26K ﹤0.01% 1712
2018
Q3 		$59K Buy
98
+37
+61% +$24.1K ﹤0.01% 1666
2018
Q2 		$46K Sell
61
-5
-8% -$3.61K ﹤0.01% 1897
2018
Q1 		$51K Buy
66
+5
+8% +$4.09K ﹤0.01% 1667
2017
Q4 		$46K Sell
61
-21
-26% -$16.2K 0.01% 1395
2017
Q3 		$69K Buy
82
+68
+486% +$56.9K 0.01% 1695
2017
Q2 		$13K Buy
14
+13
+1,300% +$11K ﹤0.01% 1465
2017
Q1 		$1K Sell
1
-1
-50% -$938 ﹤0.01% 2854
2016
Q4 		$2K Sell
2
-11
-85% -$11.4K ﹤0.01% 3465
2016
Q3 		$26K Buy
13
+11
+550% +$20.5K ﹤0.01% 1469
2016
Q2 		$3K Sell
2
-7
-78% -$11.8K ﹤0.01% 3745
2016
Q1 		$16K Buy
9
+8
+800% +$12.7K ﹤0.01% 1521
2015
Q4 		$2K Hold
1
– – ﹤0.01% 3810
2015
Q3 		$1K Sell
1
-27
-96% -$65.2K ﹤0.01% 3680
2015
Q2 		$75K Buy
+28
New +$72.7K 0.01% 1065
2014
Q4 		– Sell
-1
Closed -$4K – 4688
2014
Q3 		$4K Sell
1
-24
-96% -$78K ﹤0.01% 3461
2014
Q2 		$87K Buy
+25
New +$88.9K 0.01% 980
2014
Q1 		– Sell
-10
Closed -$38K – 4929
2013
Q4 		$38K Buy
10
+8
+400% +$28.8K 0.01% 1635
2013
Q3 		$7K Sell
2
-2
-50% -$5.85K ﹤0.01% 3462
2013
Q2 		$10K Buy
+4
New +$9.95K ﹤0.01% 2382

Other funds holding TRIB

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Tower Research Capital (TRC)'s TRIB Position: Q4 2019 in Review

Tower Research Capital (TRC) sold out of Trinity Biotech (TRIB) in Q4 2019, closing a stake of 1 share.

Tower Research Capital (TRC) first reported a position in TRIB in Q2 2013 and held it in 23 quarters. The position peaked at $87K in Q2 2014. 25 funds tracked by Wall St. Rank hold TRIB as of Q4 2019.

  • Tower Research Capital (TRC) reported no remaining Trinity Biotech position as of Q4 2019 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1 Trinity Biotech share in Q4 2019.
  • Tower Research Capital (TRC) first reported a position in Trinity Biotech in Q2 2013 and held it in 23 quarters.
  • Tower Research Capital (TRC)'s Trinity Biotech position peaked at $87K in Q2 2014.
  • 25 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2019.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.